Search results for "Papilloma"

showing 10 items of 266 documents

TLR4 down-regulation identifies high risk HPV infection and integration in head and neck squamous cell carcinomas

2015

TLRs are main actors of the innate immune response against HPV. There are very few studies on the role of TLRs mediated HPV clearance in Head and Neck oncology. Our aim was to evaluate whether TLR4 expression identifies HPV infection and/or HR-HPV integration status in oral and oropharyngeal cancers. By immunohistochemistry we assessed TLR4 levels in OSCC/OPSCC. To detect viral integration or episomic status In situ hybridization for HPV-DNA and Pyro-sequencing techniques have been performed. The relationship between TLR4 expression with HPV infection status has been investigated. ISH HPV positive samples have reported lower levels of TLR4 intensity than negative samples (p = .002). There w…

Oncology0301 basic medicineAdultMalemedicine.medical_specialtyVirus IntegrationCellDown-RegulationIn situ hybridizationBiologyAlphapapillomavirusGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesRetrospective StudieInternal medicineCarcinomamedicineHumansVirus IntegrationIn Situ HybridizationRetrospective StudiesAgedAged 80 and overInnate immune systemGeneral Immunology and MicrobiologyHead and Neck NeoplasmAlphapapillomaviruExpression indexHPV infectionvirus diseasesMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsToll-Like Receptor 4medicine.anatomical_structure030104 developmental biologyHead and Neck NeoplasmsImmunologyDNA ViralCarcinoma Squamous CellImmunohistochemistryFemaleHuman
researchProduct

Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.

2013

Contribution over time of human papillomavirus (HPV) types in human cancers has been poorly documented. Such data is fundamental to measure current HPV vaccines impact in the years to come. We estimated the HPV type-specific distribution in a large international series of invasive cervical cancer (ICC) over 70 years prior to vaccination. Paraffin embedded ICC cases diagnosed between 1940 and 2007 were retrieved from eleven countries in Central-South America, Asia and Europe. Included countries reported to have low-medium cervical cancer screening uptake. Information on age at and year of diagnosis was collected from medical records. After histological confirmation, HPV DNA detection was per…

OncologyAdultCancer ResearchInvasive cervical cancermedicine.medical_specialtyAsiavirusesUterine Cervical NeoplasmsHPV vaccinesLogistic regressionInternal medicinemedicineHumansNeoplasm InvasivenessHuman papillomavirusEarly Detection of CancerAgedRetrospective StudiesGynecologyCervical cancerHuman papillomavirus 16Paraffin EmbeddingHuman papillomavirus 18business.industryTime trendsMedical recordvirus diseasesCentral AmericaMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsVaccinationEuropeLogistic ModelsOncologyDNA ViralFemalebusinessInternational journal of cancer
researchProduct

Biopsy vs. brushing: comparison of two sampling methods for the detection of HPV-DNA in squamous cell carcinoma of the oral cavity

2012

Background: HR HPV infection was proposed as aetiological factor of oral squamous cell carcinomas (OSCC). HPV frequency in OSCC is highly variable, due to the discrepancy in oral sampling procedures, HPV testing methods and inclusion criteria regarding tumour site (strictly oral cavity vs. nearby structures). Our aim was to compare HPV DNA frequency and type-specific distribution in paired cytological and histological samples of SCC strictly located in oral cavity. The correlation between HPV detection rate by each method of sampling and demographical, behavioural and clinical-pathological variables was also examined. Patients and methods: HPV DNA was detected in brushed cells and formalin-…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyPathologySettore MED/07 - Microbiologia E Microbiologia ClinicaConcordanceBiopsyBiologySettore MED/08 - Anatomia PatologicaOral cavitySettore MED/28 - Malattie OdontostomatologicheInternal medicineStatistical significanceGenotypeBiopsymedicineCarcinomaHumansPapillomaviridaeAgedAged 80 and overmedicine.diagnostic_testHPV infectionMiddle Agedmedicine.diseasestomatognathic diseasesHpv testingBiopsy Brushing Human Papilloma Virus (HPV) infection Methods of sampling Oral squamous cell carcinoma (OSCC) Tonsillar squamous cell carcinoma (TSCC) Oropharyngeal squamous cell carcinoma(OPSCC) Head and neck squamous cell carcinoma(HNSCC) Oral cavityOncologyDNA ViralCarcinoma Squamous CellFemaleMouth NeoplasmsOral Surgery
researchProduct

The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: a retrospective analysis of 88 patients and literature ove…

2014

In addition to tobacco and alcohol consumption, the two main risk factors for oral squamous cell carcinoma (OSCC), recent studies have revealed infections with human papilloma virus (HPV) as an additional risk factor for OSCC development. In the field of head and neck malignancies, the prevalence of HPV infections in oropharyngeal cancer (OC) ranges in different studies up to 84%. While HPV infection is discussed as an independent risk factor in this region, its distinguished role in carcinogenesis of tumours localized to the oral cavity remains still uncertain. In this study, we analysed the HPV status in 88 consecutive patients with OSCCs localized anterior of the palatoglossal arch who w…

OncologyAdultMalemedicine.medical_specialtyPathologyAlcohol DrinkingCarcinogenesisCellAlphapapillomavirusmedicine.disease_causePalatine tonsilYoung AdultSex FactorsInternal medicineGermanyPrevalenceMedicineHumansRisk factorAgedNeoplasm StagingRetrospective StudiesHuman papilloma virusAged 80 and overHuman papillomavirus 16Human papillomavirus 18business.industryPapillomavirus InfectionsSmokingHPV infectionAge Factorsvirus diseasesCancerMiddle Agedmedicine.diseasestomatognathic diseasesOropharyngeal Neoplasmsmedicine.anatomical_structureOtorhinolaryngologyOral and maxillofacial surgeryCarcinoma Squamous CellSurgeryFemaleMouth NeoplasmsOral SurgerybusinessCarcinogenesisJournal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
researchProduct

Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and…

2001

OBJECTIVE To assess whether the presence of human papilloma virus (HPV) DNA and/or several genotypes of HPV DNA in primary cervical cancer and cancer free pelvic lymph nodes are correlated with several clinicopathological parameters of well-defined prognostic significance and whether virological parameters are predictors of long-term survival in cancer patients. PATIENTS AND METHODS 223 cases of cervical cancer patients included in this retrospective study underwent follow-up evaluation. Survival and cause of death were examined for 204 (91.4%) patients, with a mean follow-up time of 4.4 years. HPV DNA was detected using the high sensitive polymerase chain reaction (PCR) method followed by …

OncologyAdultmedicine.medical_specialtyGenotypeUterine Cervical NeoplasmsAdenocarcinomaPolymerase Chain Reactionlaw.inventionCarcinoma AdenosquamouslawInternal medicineGenotypeMedicineHumansNeoplasm InvasivenessLymph nodePapillomaviridaePolymerase chain reactionAgedRetrospective StudiesCervical cancerAged 80 and overbusiness.industryPapillomavirus InfectionsObstetrics and GynecologyCancerMiddle Agedmedicine.diseasePrognosisPrimary tumorSurvival AnalysisKoilocyteTumor Virus Infectionsmedicine.anatomical_structureLymphatic MetastasisDNA ViralCarcinoma Squamous CellFemaleLymphLymph NodesbusinessFollow-Up StudiesZentralblatt fur Gynakologie
researchProduct

The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the De…

2001

The objective of this study was to assess whether the presence of human papillomavirus (HPV) DNA and/or several genotypes of HPV DNA in cervical cancer are correlated with several clinicopathologic parameters of well-defined prognostic significance and whether virologic parameters are predictors of long-term survival in cancer patients. Two hundred twenty three cases of cervical cancer patients included in this retrospective study underwent follow-up evaluation. Survival and cause of death were examined for 204 (91.4%) patients, with a mean follow-up time of 4.4 years. HPV DNA was detected using the highly sensitive polymerase chain reaction (PCR) method followed by HPV DNA sequencing for H…

OncologyAdultmedicine.medical_specialtyGenotypeUterine Cervical NeoplasmsAdenocarcinomaPolymerase Chain Reactionlaw.inventionCarcinoma AdenosquamouslawInternal medicineGenotypemedicineCarcinomaHumansPapillomaviridaePapillomaviridaeSurvival analysisPolymerase chain reactionAgedRetrospective StudiesGynecologyCervical cancerAged 80 and overbiologybusiness.industryPapillomavirus Infectionsvirus diseasesObstetrics and GynecologyCancerMiddle Agedmedicine.diseasebiology.organism_classificationPrognosisSurvival Analysisfemale genital diseases and pregnancy complicationsTumor Virus InfectionsOncologyDNA ViralCarcinoma Squamous CellAdenocarcinomaFemalebusinessInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society
researchProduct

Distribution of human papillomavirus types in women from Valencia, Spain, with abnormal cytology.

2010

Objective To determine human papillomavirus (HPV) types among cervical smears using polymerase chain reaction (PCR) and to contribute to the knowledge of human papillomavirus genotype distribution and prevalence of oncogenic types in cervical lesions in Spain. Study Design Consensus PCR and direct sequencing of PCR products (DNA HPV typing) were used in a retrospective study to determinate the type or types of HPV on 974 cytology smears of women with abnormal cytology results. Results Of 974 smears, 79.8% were high-risk (H-R) HPVs, 19.7% low-risk (L-R) HPVs, 4.6% indeterminate-risk (I-R) HPVs, considering both single and multiple infections. Multiple infections were detected in 4.7% of the …

OncologyAdultmedicine.medical_specialtyHistologyGenotypeCost effectivenessPopulationPrevalenceUterine Cervical NeoplasmsAlphapapillomavirusCervical intraepithelial neoplasiaPolymerase Chain ReactionPathology and Forensic MedicineGene FrequencyCytologyInternal medicineGenotypemedicinePrevalenceHumansMass ScreeningeducationMass screeningRetrospective StudiesGynecologyVaginal Smearseducation.field_of_studyHuman papillomavirus 16Human papillomavirus 18business.industryPapillomavirus Infectionsvirus diseasesGeneral Medicinemedicine.diseaseUterine Cervical Dysplasiafemale genital diseases and pregnancy complicationsSquamous intraepithelial lesionSpainDNA ViralFemalebusinessActa cytologica
researchProduct

Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention

2011

Objective. Human papillomavirus (HPV) genotype distribution in invasive cervical cancer (ICC) is critical to guide the introduction and to assess the impact of HPV prophylactic vaccines. This study aims to provide specific information for Spain. Methods. 1043 histological confirmed ICC cases diagnosed from 1940 to 2007 from six Spanish regions were assembled. HPV DNA detection was performed by SPF10 broad-spectrum PCR followed by deoxyribonucleic acid enzyme immunoassay and genotyping by reverse hybridization line probe assay (LiPA(25)) (version 1). Results. Of 1043 ICC cases, 904 were HPV DNA positive (adjusted prevalence: 89.1%). The eight most common types, in decreasing order, were HPV …

OncologyAdultmedicine.medical_specialtyInvasive cervical cancerGenotypeUterine Cervical NeoplasmsHPV vaccinesAdenocarcinomaAlphapapillomavirusInternal medicineGenotypemedicineHumansPapillomavirus VaccinesHuman papillomavirusGenotypingAgedGynecologyCervical cancerHuman papillomavirus 16HPV typesVaccinesHpv typesHuman papillomavirus 18business.industryHPV PositivePapillomavirus Infectionsvirus diseasesObstetrics and GynecologyTime trendsMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsOncologySpainCervical cancerFemalebusiness
researchProduct

Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in S…

2017

ABSTRACT While bivalent and quadrivalent HPV vaccines have been used for about 10 years, a nonavalent vaccine against HPV types 6/11/16/18/31/33/45/52 and 58 has been recently approved by FDA and EMA and is now commercially available. The objective of our study was to evaluate the potential impact of the nonavalent vaccine on HPV infection and related low- and high-grade squamous intraepithelial lesions (LSIL, HSIL), compared to the impact of the quadrivalent vaccine, in a female population living in Sicily (Italy). Low estimates of HPV vaccine impact were calculated as prevalence of HPV 6/11/16/18/31/33/45/52 and 58 genotypes, alone or in association, but excluding presence of other HPV ty…

OncologyAdultmedicine.medical_specialtyReferralGenotypeImmunologyUterine Cervical NeoplasmsHPV vaccinesCervix UteriHospital based study03 medical and health sciences0302 clinical medicineHuman Papillomavirus Recombinant Vaccine Quadrivalent Types 6 11 16 18Internal medicinevaccineGenotypemedicinePrevalenceHumansImmunology and Allergy030212 general & internal medicinePapillomavirus VaccinesquadrivalentReferral and ConsultationSicilyFemale populationsquamous intraepithelial lesionGynecologyPharmacologyPotential impactHpv typesbusiness.industryPapillomavirus InfectionsHPV infectionsquamous intraepithelial lesionsvirus diseasesmedicine.diseaseUterine Cervical DysplasiaResearch Papersimpact estimateHPV infection; impact estimate; nonavalent; quadrivalent; squamous intraepithelial lesions; vaccine; Immunology and Allergy; Immunology; Pharmacology030220 oncology & carcinogenesisHPV infectionFemalebusinessnonavalent
researchProduct

Low Frequency of Human Papillomavirus in Strictly Site-Coded Oral Squamous Cell Carcinomas, Using the Latest NHI/SEER-ICD Systems: A Pilot Observatio…

2021

Simple Summary The incidence of oropharyngeal squamous cell carcinomas (OPSCCs) has increased in the last decades, and this seems to be correlated to the infectious epidemiological trend of human papillomavirus (HPV). The prevalence of HPV-positive OPSCCs is approximately 70%, with involvement mainly of the tonsillar area. On the role of HPV in oral squamous cell carcinoma (OSCC), very few studies have investigated the prevalence of HPV in strictly site-codified OSCC, excluding the base of the tongue as distinct oropharyngeal entity. As a result, an inappropriate estimation of HPV infection in OSCC has been observed. We investigated HPV status, using a combination of detection methods, in a…

OncologyCancer Researchmedicine.medical_specialtyCellmedicine.disease_causeArticleInternal medicineNIH/SEER ICD-0-3.2EpidemiologymedicineHuman papillomavirushuman papillomavirusRC254-282Human papillomavirus oral squamous cell carcinoma NIH7 SEER ICD-0-3.2p16 IHCPCR HPV-DNAbusiness.industryHPV infectionNeoplasms. Tumors. Oncology. Including cancer and carcinogensCancervirus diseasesmedicine.diseaseoral squamous cell carcinomastomatognathic diseasesmedicine.anatomical_structurePCR HPV-DNA P16 ihcOncologyImmunohistochemistryObservational studybusinessCarcinogenesisCancers
researchProduct